Feldan Announces the Appointment of Eric Carter, PH.D., M.D., to its Board of Directors
22 Jan 2025
Quebec City, Canada, January 22, 2025 — Feldan Therapeutics (“Feldan”), a clinical-stage pharmaceutical company specializing in the development of treatments based on intracellular delivery of therapeutics, is pleased to announce the appointment of Dr. Eric Carter to its Board of Directors.